Type 1 diabetes (T1D) is an autoimmune disease in which insulin-producing beta cells are destroyed in the islets of Langerhans. One of its main pathological manifestations is the hyper-expression of Major Histocompatibility Complex I (MHC-I) by beta cells, which was first described over 3 decades ago yet its cause remains unknown. It might not only be a sign of beta cell dysfunction but could also render the cells susceptible to autoimmune destruction; for example, by islet-infiltrating CD8 T cells. In this report, we studied pancreas tissue from a 22-year-old non-diabetic male cadaveric organ donor who had been at high risk of developing T1D, in which autoantibodies against GAD and IA-2 were detected. Pancreas sections were analyzed for signs of inflammation. Multiple insulin-containing islets were identified, which hyper-expressed MHC-I. However, islet density and MHC-I expression exhibited a highly lobular and heterogeneous pattern even within the same section. In addition, many islets with high expression of MHC-I presented higher levels of CD8 T cell infiltration than normal islets. These results demonstrate the heterogeneity of human pathology that occurs early during the pre-diabetic, autoantibody positive phase, and should contribute to the understanding of human T1D. (J Histochem Cytochem 63:626-636, 2015) 
Introduction
Pathological changes take place before the complete destruction of insulin-producing beta cells in the pancreatic islets of pre-diabetic individuals and might offer us insight into the earlier events underlying diabetes development. These coincide with the appearance of autoantibodies, which constitute, nowadays, the most common tool to predict future diabetes development (Pihoker et al. 2005) . Usually, antibodies against insulin (IA) appear first, followed by the presence of autoantibodies against glutamate decarboxylase (GAD), insulinomaassociated protein 2 (IA-2) and zinc transporter 8 (ZnT8) (Gorus et al. 2013) . Around the time of diagnosis, beta cell function is relatively rapidly lost but, in most cases, a significant residual number of functional beta cells can still be present, and they can be retained over many years (Coppieters et al. 2012; Coppieters et al. 2011; Gianani et al. 2010; Keenan et al. 2010) . It is known that during the early pre-diabetic state, beta cells can show an abnormal phenotype with one pathognomonic sign being the increase in Major Histocompatibility Complex I (MHC-I) expression in both insulin-deficient and insulin-containing islets (Coppieters et al. 2012; Foulis et al. 1987a; Quah et al. 2014 ). This phenomenon was described 30 years ago by Bottazo at el. (1985) and by Foulis and colleagues (Foulis et al. 1987a) . The trigger or cause of this elevated expression is still not understood.
As the disease progresses, a lymphocytic infiltration can be observed in some islets. This phenomenon, described more 6543J HCXXX10.1369/0022155415576543Rodriguez-Calvo et al.Histopathology of Pre-Diabetes than 100 years ago by Schmidt (1902) , was named insulitis by Von Meyenburg in 1940 and studied by LeCompte and Gepts in 1958 and in 1965, respectively . It is somewhat better characterized today and we know that the most frequent cell types are CD8 lymphocytes, followed by macrophages, B cells and CD4 T cells ). However, only a few studies have been carried out in non-diabetic, autoantibody positive (Ab+) donors, with the majority of the donors showing no leukocytic infiltration or beta cell damage (Gianani et al. 2006; In't Veld et al. 2007; Wagner et al. 1994) . The Network for Pancreatic Organ Donors with Diabetes (nPOD) has now opened up the unique possibility of investigating and characterizing the histopathological presentation of all the stages of the disease, from the pre-diabetic to the chronic state. In the present study, we investigated the pancreas of a double Ab+ cadaveric organ donor who had been at high risk of developing type 1 diabetes (T1D). We show that high MHC-I expression and CD8 T cell infiltration are remarkably heterogeneously distributed and differentially affect islets situated in different regions of the pancreas, creating a multifocal pattern. The cause(s) for this lobularity remain unclear, among them the potential for viral infections, the inflammatory milieu in the pancreas, as well as the intrinsic etiology.
Materials & Methods

Subject
Human pancreata were collected from a cadaveric organ donor through the Network for Pancreatic Organ donors with Diabetes (nPOD). Six-μm sections from frozen pancreas samples from three different blocks from the head (#02, #04 and #06), body (#02, #06 and #08) and tail (#02, #04 and #06) regions were obtained from case number 6197 (male, 22 years old, African American). All experimental procedures were approved by the La Jolla Institute for Allergy and Immunology Institutional Review Boardapproved protocol number DI3-054-1112.
Immunofluorescence for Insulin, HLA-ABC and CD8
Sections were subject to a standard immunofluorescence staining protocol. Briefly, sections were fixed with 0.4% paraformaldehyde and blocked with goat serum. Staining for insulin and human leukocyte antigens (HLA)-ABC (MHC-I) was performed at room temperature for 1 hr using the following antibodies: polyclonal guinea pig anti-insulin (1/140; Dako, Carpinteria, CA) and mouse monoclonal (clone W6/32) IgG2a against a monomorphic epitope on the 45-kD polypeptide products of the HLA-A, B and C loci (1/100; Dako, Carpinteria, CA). Detection was done at room temperature for 45 min using polyclonal goat anti-guinea pig IgG, highly cross-adsorbed, Alexa Fluor 488 (1/1000; Invitrogen, Grand Island, NY) and polyclonal goat antimouse IgG2a, isotype-specific Alexa Fluor 594 (1/1000; Invitrogen, Grand Island, NY). Finally, sections were incubated for 1 hr at room temperature with mouse monoclonal anti-CD8 (clone RFT8, IgG1) conjugated to Alexa Fluor 647 (1:50; Southern Biotech, Birmingham, AL). After washing, sections were mounted with ProLong Gold antifade reagent (Molecular Probes, Grand Island, NY). Control pancreatic tissue sections with only secondary antibodies were used to determine non-specific staining.
Image Acquisition and Analysis
Images were acquired using a Zeiss Axio Scan Z.1 slide scanner (10× objective) and Zen software, Blue edition (Zeiss, Oberkochen, Germany). Whole tissue section images were divided into multiple smaller areas using a grid in order to facilitate analysis. Islets were then counted manually based on insulin staining, and islet density calculated per section based on the number of islets and the total area of the tissue using a custom macro developed for ImageJ (National Institutes of Health, Bethesda, MD). MHC-I expression was qualitatively evaluated and every islet classified based on the intensity and distribution of MHC-I staining as normal (no detectable expression by endocrine cells), elevated (high expression by endocrine cells not affecting the whole islet area) or hyper-expressing (high expression by endocrine cells affecting all the islet area). Infiltrating CD8 T cells were manually counted in each islet and matched to the MHC-I pattern. The percentages of elevated and hyperexpressing islets combined (MHC-I immunoreactive islets) were calculated and is represented as a heat map by using the Excel conditional format tool (Microsoft, Redmond, WA). The lowest values were assigned green tones and the highest, red tones. The same process was applied to CD8 T cell values per MHC-I immunoreactive islet section.
Statistical Analysis
Group differences were analyzed by using Kruskal-Wallis non-parametric test followed by Dunn test for multiple comparisons. Correlation analysis was done by using Spearman correlation with two-tailed significance test. All analyses were performed using GraphPad Prism version 6 (GraphPad Software, San Diego, CA). Data in bar graphs are presented as mean ± SD. Findings were assumed statistically significant at p≤0.05.
Results
Demographic Characteristics of Case #6197
The donor described in this manuscript was male, 22 years old, with a body mass index of 28.2, of African American descent, and positive for IA-2 and GAD autoantibodies. High HLA resolution analysis showed the following genotype: A*02:02, 24:02; DRB1*03:02, 07:01; DQA1*02:01, 04:01; DQB1*02:02, 04:02. The nPOD pathology core indicated the presence of multiple insulin-and glucagon-positive islets at first screening. Some insulitis was also reported (rare) as well as islet hyperemia. Finally, a mild, multifocal chronic pancreatitis was described. The donor was found to be positive for cytomegalovirus (CMV) and Epstein-Barr virus (EBV) IgG in the serum.
Systematic Histological Analysis of Pancreatic Sections
Frozen pancreatic sections from three different blocks prepared from the head, body and tail of the pancreas were analyzed (head blocks #02, #04 and #06; body blocks #02, #06 and #08 and tail blocks #02, #04 and #06). Each section was divided into several quadrants using a grid. In each of these areas, islets were manually counted (Fig. 1) . The number of total islets varied depending on the section and region. A Figure 1 . Frozen pancreatic tissue sections were stained for insulin (green), MHC-I (red), CD8 (white) and DAPI (blue) following a standard immunofluorescence protocol. Sections were scanned and divided into smaller areas using a grid in order to facilitate analysis. A letter was assigned to each quadrant (A-P). Whole-tissue images are shown for each of the sections. Only insulin and DAPI staining are depicted for clarity purposes. White dots indicate islets. Scale, 1000 µm. minimum of 183 islets were counted in the head block #04, whereas 656 islets were detected in the tail block #04 ( Fig.  2A) . Islet density was then calculated based on the total tissue area and ranged from 2.04 islets/mm 2 to 4.80 islets/mm 2 and was found to be higher in the pancreatic head and tail (3.61 vs 3.33 islets/mm 2 ) than in the body (2.41 islets/mm 2 ) ( Fig. 2A ). Islets were then classified based on the level of MHC-I expression as normal (no detectable expression in endocrine cells), elevated (high expression of MHC-I by endocrine cells not affecting the whole islet area) and hyper-expressing (high expression of MHC-I by endocrine cells affecting all the islet area) (Fig. 2B) .
MHC-I Hyper-expression Is Heterogeneously Distributed across Multiple Islets and Regions in the Pancreas
To study islet MHC-I expression and localization in the pancreas, staining for insulin and MHC-I was performed across multiple sections and blocks from the head, body and tail of the pancreas. The number of islets and the expression of MHC-I was analyzed manually for each section and the data are represented as bar graphs and heat maps (see Materials & Methods) . In head block #02, 444 islets were counted. Of these, 7.61% (range, 0% to 32%; A to M) and 13.24% (range, 0% to 50%, A to M) of the islets showed elevated MHC-I expression and hyper-expression, respectively (Figs. 3A, 4A ). In head blocks #04 and #06, 183 and 221 islets were counted. Whereas elevated islets constituted 6.50% (range, 0% to 33.3%; A to L) and 3.94% (0% to 21.7%; A to K), respectively, hyper-expression was detected in 5.18% (0% to 36.3%; A to L) and 2.63% (0% to 47.6%, A to K) in these two blocks (Figs. 3B, 3C, 4A ). Overall, combined elevated and hyper-expressing islets (MHC-I immunoreactive phenotype) constituted 13.43% of the islets in the head region.
Next, we performed the same analysis for body and tail regions. A total of 420, 546 and 278 islets were counted in body blocks #02, #06 and #08, respectively. Of this, 7.99% (range, 0% to 20.6%; A to P), 7.50% (range, 0% to 17%; A to P), and 10.82% (range, 0% to 34.8%; A to M) of the islets presented elevated MHC-I expression, whereas a lower number of islets was found to hyper-express it in each of the body blocks (4.05% (range, 0% to 11.3%; A to P), 5.17 (range, 0% to 40%; A to P), and 8.78% (range, 0% to 33.3%, A to M) respectively; Figs. 3D-3F, 4B). In the tail, 290, 656 and 480 islets were counted in blocks #02, #04 and #06, respectively, with 3.19% (range, 0% to 12.5%; A to M), 9.67% (0% to 33.3%; A to N) and 8.74% (range, 0% to 37.5%; A to P) presenting increased MHC-I expression. Hyper-expressing islets were found to be lower in this region, with 0.73% (range, 0% to 9.5%; A to M), 8.13% (range, 0% to 32.1%; A to N) and 4.75% (range, 0% to 34.8%; A to P) measured in the islets for tail blocks #02, #04 and #06, respectively (Figs. 3G-3I, 4C) . No significant differences were found between different blocks except for tail block #02 which presented a lower percentage of MHC-I immunoreactive islets than the other blocks ( Fig. 4A-4C) . Finally, values from all regions were combined in a heat map in which the areas with higher percentages of MHC-I immunoreactive islets are shown in red tones whereas those areas containing mainly normal islets are depicted in green. We found that higher percentages of MHC-I immunoreactive islets were present in head blocks #02 and #04, body block #08 and tail block #04. Conversely, normal islets were scattered across all of the blocks (see overall data, presented later in Fig. 7A ).
The affected islets (elevated and hyper-expressing islets combined) constituted 13.4% of the islets in the body section of the pancreas, which was almost the same percentage as that found in the head (14.4%) and the tail (11.9%) sections. In addition, no significant differences were detected between head, body and tail regions regarding the percentages of elevated, hyper-expressing or normal islets (Fig. 4D-4F ).
CD8 T Cells Preferentially Infiltrate Islets with High Levels of MHC-I Expression
To evaluate the possible link between high MHC-I expression and infiltration, CD8 T cells were quantified on a per islet basis and correlated with their MHC-I pattern. High infiltration was only noticed in some islets. Similar values of CD8 T cells per elevated or hyper-expressing islet were found in head block #02 (mean values of 2.73 and 3.81 CD8 T cells per islet, respectively). In head block #04, mean values of 1.79 and 7.86 CD8 T cells were found to infiltrate elevated and hyper-expressing islets, whereas 4.91 and 2.85 CD8 T cells were found in head block #06 for MHC-I immunoreactive islets (Figs. 5A-5C, 6A) . Accordingly, similar values were found for elevated islets in body block #02 and #06 (2.53 vs 2.19) whereas body block #08 had a lower level of infiltration (0.91 CD8 T cells/elevated islet section). Similarly, hyper-expressing islets were infiltrated by a mean of 2.64, 2.51 and 0.86 CD8 T cells/islet section in blocks #02, #04 and #06, respectively (Figs. 5D-5F, 6B). Finally, no major differences were found in the tail between regions. Infiltration ranged from 1.93 to 2.42 CD8 T cells per elevated islet and from 2.28 to 2.9 CD8 T cells per hyper-expressing islet in the tail blocks analyzed (Figs. 5G-5I, 6C) .
Across the three blocks examined in each of the three regions, normal islets presented similar numbers of infiltrating CD8 T cells. In the head region, mean values of 0.43, 0.50 and 0.40 CD8 T cells per islet section were found for blocks #02, #04 and #06. The three blocks from the body presented with mean values of 0.33, 0.29 and 0.55 CD8 T cells per islet section, whereas the tail showed 0.56, 1.22 and 0.98 CD8 T cells, respectively (Fig. 6A-6C) .
Overall, islets with high MHC-I expression presented a higher number of infiltrating CD8 T cells than normal islets in all blocks. In addition, these differences were significant in head, body and tail regions. No differences were found between elevated and hyper-expressing islet infiltration in any of the analyzed areas (Fig. 6) . Lastly, values from all regions were placed together in a heat map in which the areas with higher number of infiltrating CD8 T cells per islet section are shown in red tones whereas quadrants containing less CD8 T cells are depicted in green. We found the highest number of infiltrating CD8 T cells per islet in head block #02 and tail blocks #04 and #06, and reduced numbers scattered across all of the blocks, particularly in tail block #02 (Fig. 7B) .
Correlation analysis between the percentages of MHC-I immunoreactive islets and the number of CD8 T cells per islet section in each quadrant showed strong correlation (r = 0.6) with a moderate linear fit (Fig. 7C) .
Discussion
In the present study, we have performed a systematic analysis of two pathognomonic signs of early diabetes, MHC-I expression and CD8 T cell infiltration into islets. Pancreatic samples from a double Ab+ individual with no clinical signs of diabetes showed high MHC-I expression affecting approximately 14% of the islets in head and body and 12% in the tail of the pancreas. Differences in islet density and affected islets could be due to the samples analyzed and cannot be linked to disease progression by themselves. Areas of islets with normal MHC-I expression were frequently contiguous with areas of hyper-expressing islets. In some of these areas, almost 50% of the islets showed hyperexpression of MHC-I. In addition, we observed an intermediate level of expression that was apparent in some islets. In these so-called "elevated islets" not all of the endocrine cells within the islet expressed MHC-I. Their distribution was also scattered across the pancreatic sections. Hence, islets with a MHC-I immunoreactive phenotype (elevated and hyper-expressing MHC-I) presented a patchy and sometimes lobular distribution. CD8 T cell infiltration, although mild, was also detected in the affected islets and was, on average, higher in islets with high MHC-I (elevated and hyper-expression) as compared with islets with a normal MHC-I expression. In 1985, a case report by Botazzo and colleagues described the pathological findings in the pancreas of a 12-year-old girl with newly-diagnosed T1D, who died within 24 hours of diagnosis (Bottazzo et al. 1985) . In this important study, "a marked increase" in MHC-I (HLA-A, B and C) expression was observed in some islets. In addition, analysis of islet infiltration showed the presence of a predominant cytotoxic T cell population (Bottazzo et al. 1985) . In 1987, Foulis and colleagues confirmed the presence of a high expression of MHC-I molecules on endocrine cells from type 1 diabetic donors, while elevated levels were uncommon in the islets of non-diabetic donors (Foulis et al. 1987a) . It was also mentioned that the frequency of hyperexpression of MHC-I by insulin-containing islets could be accurately estimated from a single section. At that time, the possible underestimation of pathological alterations like insulitis based on the sole analysis of one tissue section from one particular block was a concern (Foulis et al. 1987a) . In the present study, we have performed a comprehensive and systematic analysis in multiple blocks from the pancreatic head, body and tail to overcome this possible limitation. As shown here, the lobularity and heterogeneity of the human disease increases the complexity of possible pathological interpretations and therefore conclusions obtained from the study of one tissue section should, in general and depending on the targeted molecule or cell, be interpreted with caution.
Insulitis is present in both mice and humans but major differences have been reported. In mouse models, infiltration starts in the peri-islet area and it is comparatively massive, whereas, in humans, as described here, it is usually mild. Additionally, we and others have shown that only a small percentage of islets are inflamed during the pre-diabetic phase (Coppieters et al. 2012; In't Veld et al. 2007) . Conversely, almost all of the islets from 18-weekold Non-Obese Diabetic (NOD) mice show heavily infiltration (Carrero et al. 2013; Eisenbarth 1986 ). Furthermore, in both NOD mice and humans, islet beta cells up-regulate MHC-I during the inflammatory response, and this process is important for disease progression. As reported by Hamilton-Williams et al. (2003) , MHC-I influences beta cell destruction by infiltrating cytotoxic T cells. NOD mice lacking MHC-I expression on beta cells presented with the same level of insulitis as those with normal MHC-I expression levels but hyperglycemia was delayed or abolished. Our results additionally show that there is a strong correlation between islet MHC-I expression and infiltrating CD8 T cells in humans. Areas containing mostly normal islets presented a lower but still evident number of CD8 T cells per islet section as compared with those with a higher percentage of MHC-I immunoreactive islets. This could indicate that CD8 T cells infiltrate the islets even before the up-regulation of MHC-I. However, the opposite might also be true, as similar numbers of CD8 T cells have been previously found in the islets of nondiabetic individuals (Rodriguez-Calvo et al. 2014 ). The differences between mice and human pathology are therefore intriguing, and may reflect the etiology or primary cause of the disease; these differences, however, may also just reflect an overall slower disease course in humans (years versus months in mice).
The link between MHC-I hyper-expression and virus infection has often been debated over the past 30 years. Our results here cannot confirm the presence of a viral infection but the lobular pattern is indicative of the usual patchy appearance of viral antigen found during infection in a solid organ (Capua et al. 2013; Honeyman et al. 2014; Schneider and von Herrath 2014) . Infection of some islets might trigger an antiviral response and therefore an increase in MHC-I (Foulis et al. 1987b ). For example, growing evidence suggests that enteroviruses (EV) or neutralizing antibodies against them can be detected in pancreata and in the serum from T1D donors (Laitinen et al. 2014; Oikarinen et al. 2014; Richardson et al. 2013; Richardson et al. 2009; Schneider and von Herrath 2014; Willcox et al. 2011) . EV can effectively infect beta cells, which express the coxsackievirus and adenovirus receptor (CAR) (Oikarinen et al. 2008; Ylipaasto et al. 2004) . Infection of beta cells could trigger the release of interferons and islet antigens (Hober and Sauter 2010) , which might be recognized by auto-reactive T cells and result in autoimmune destruction. However, no EV proteins or genome were detected in the pancreas of this particular autoantibody positive donor by immunohistochemistry and PCR (Richardson S. and Oikarinen M., personal communication) . We cannot completely rule out the presence of a viral infection, as not all of the regions of the pancreas were analyzed. In addition, a previous infection could have taken place, as it has been shown that EVs can persist due to deletions in their genome that make the virus an extremely slow replicator and displace the wild type forms during a chronic infection (Tracy et al. 2014) . Additional and new techniques will be needed to detect these terminally deleted viruses in pancreata from pre-or diabetic individuals to ascertain their possible role(s) in the pathogenesis of T1D. Slow-replicating, endogenous and/or latent viruses like herpesviruses may also be good candidates, as they are commonly found in humans and can persist in the pancreas without exhibiting cytopathic effects (Marguerat et al. 2004; Mason et al. 2014; Ramondetti et al. 2012) . The MHC-I pattern shown here could match a possible lobular spreading of these viruses.
In conclusion, in this systematic study, MHC-I expression and CD8 T cell infiltration have been analyzed on a per-islet basis in whole tissue sections from multiple regions of the pancreas. Our data indicate that, during the pre-diabetic state, islets might undergo important pathophysiological changes that occur in a patchy, almost 'vitiligo-like' fashion (Eisenbarth 2010) , and highlight the importance of understanding the precise cause of these changes. More insight into autoantibody-positive cases could reveal early pathological events of T1D and thus could also pinpoint future preventive strategies.
